Published in Eur Neuropsychopharmacol on January 01, 1995
The neurobiology of the switch process in bipolar disorder: a review. J Clin Psychiatry (2010) 1.94
Glycogen synthase kinase-3 in the etiology and treatment of mood disorders. Front Mol Neurosci (2011) 1.48
Bipolar disorder: from genes to behavior pathways. J Clin Invest (2009) 1.24
Sex differences in animal models of psychiatric disorders. Br J Pharmacol (2014) 1.15
Sleep-promoting properties of quetiapine in healthy subjects. Psychopharmacology (Berl) (2004) 1.09
Glutamate receptors as targets of protein kinase C in the pathophysiology and treatment of animal models of mania. Neuropharmacology (2008) 1.07
Experimental sleep fragmentation and sleep deprivation in rats increases exploration in an open field test of anxiety while increasing plasma corticosterone levels. Behav Brain Res (2008) 1.06
Predictive animal models of mania: hits, misses and future directions. Br J Pharmacol (2011) 1.04
Cross-species assessments of motor and exploratory behavior related to bipolar disorder. Neurosci Biobehav Rev (2010) 0.97
Sleep deprivation impairs performance in the 5-choice continuous performance test: similarities between humans and mice. Behav Brain Res (2013) 0.95
Antidepressant chronotherapeutics for bipolar depression. Dialogues Clin Neurosci (2012) 0.95
Reverse translational strategies for developing animal models of bipolar disorder. Dis Model Mech (2009) 0.94
Novel mechanistic insights into treadmill exercise based rescue of social defeat-induced anxiety-like behavior and memory impairment in rats. Physiol Behav (2014) 0.93
Strain-specific battery of tests for domains of mania: effects of valproate, lithium and imipramine. Front Psychiatry (2010) 0.86
Tamoxifen use for the management of mania: a review of current preclinical evidence. Psychopharmacology (Berl) (2014) 0.85
Dopamine transporter regulation during four nights of REM sleep deprivation followed by recovery--an in vivo molecular imaging study in humans. Sleep (2010) 0.85
Neurobiological consequences of sleep deprivation. Curr Neuropharmacol (2013) 0.80
Hyperactivity, startle reactivity and cell-proliferation deficits are resistant to chronic lithium treatment in adult Nr2e1(frc/frc) mice. Genes Brain Behav (2010) 0.79
Lithium prevents REM sleep deprivation-induced impairments on memory consolidation. Sleep (2013) 0.79
Region-specific alteration in brain glutamate: possible relationship to risk-taking behavior. Physiol Behav (2009) 0.78
Animal models of bipolar mania: The past, present and future. Neuroscience (2015) 0.78
Investigating the mechanism(s) underlying switching between states in bipolar disorder. Eur J Pharmacol (2015) 0.77
Heart rate never lies: interventional cardiologist and Braude's quote revised. Open Heart (2016) 0.77
Protein kinase C inhibition rescues manic-like behaviors and hippocampal cell proliferation deficits in the sleep deprivation model of mania. Int J Neuropsychopharmacol (2014) 0.77
Investigating the underlying mechanisms of aberrant behaviors in bipolar disorder from patients to models: Rodent and human studies. Neurosci Biobehav Rev (2015) 0.77
Effect of lithium on behavioral disinhibition induced by electrolytic lesion of the median raphe nucleus. Psychopharmacology (Berl) (2014) 0.76
A Review of Biomarkers in Mood and Psychotic Disorders: A Dissection of Clinical vs. Preclinical Correlates. Curr Neuropharmacol (2015) 0.75
Glial-specific gene alterations associated with manic behaviors. Int J Bipolar Disord (2013) 0.75
Anticonvulsant drugs in bipolar disorder. Dialogues Clin Neurosci (1999) 0.75
Chronic escitalopram treatment attenuated the accelerated rapid eye movement sleep transitions after selective rapid eye movement sleep deprivation: a model-based analysis using Markov chains. BMC Neurosci (2014) 0.75
Hypothalamic L-Histidine Decarboxylase Is Up-Regulated During Chronic REM Sleep Deprivation of Rats. PLoS One (2016) 0.75
Sleep deprivation and time-on-task performance decrement in the rat psychomotor vigilance task. Sleep (2015) 0.75
Increased sleep duration precedes the improvement of other symptom domains during the treatment of acute mania: a retrospective chart review. BMC Psychiatry (2016) 0.75
Sleep loss as a trigger of mood episodes in bipolar disorder: individual differences based on diagnostic subtype and gender. Br J Psychiatry (2017) 0.75
The Neurosteroidogenic Enzyme 5α-Reductase Mediates Psychotic-Like Complications of Sleep Deprivation. Neuropsychopharmacology (2017) 0.75
Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice. Science (1999) 4.31
Crucial role of alpha4 and alpha6 nicotinic acetylcholine receptor subunits from ventral tegmental area in systemic nicotine self-administration. J Neurosci (2008) 2.52
Identification of nine tissue-specific transcription factors of the hepatocyte nuclear factor 3/forkhead DNA-binding-domain family. Proc Natl Acad Sci U S A (1993) 2.27
Functional interaction between opioid and cannabinoid receptors in drug self-administration. J Neurosci (2001) 1.78
Clinical trials and late-stage drug development for Alzheimer's disease: an appraisal from 1984 to 2014. J Intern Med (2014) 1.75
Isolation, sequencing, synthesis, and pharmacological characterization of two brain neuropeptides that modulate the action of morphine. Proc Natl Acad Sci U S A (1985) 1.50
Cannabinoid self-administration in rats: sex differences and the influence of ovarian function. Br J Pharmacol (2007) 1.47
Cannabinoid CB1 receptor knockout mice fail to self-administer morphine but not other drugs of abuse. Behav Brain Res (2001) 1.46
Intravenous self-administration of the cannabinoid CB1 receptor agonist WIN 55,212-2 in rats. Psychopharmacology (Berl) (2001) 1.34
MicroRNA profiling reveals that miR-21, miR486 and miR-214 are upregulated and involved in cell survival in Sézary syndrome. Cell Death Dis (2011) 1.25
Self-administration of the cannabinoid receptor agonist WIN 55,212-2 in drug-naive mice. Neuroscience (1998) 1.18
The effects of novel and newly approved antipsychotics on serum prolactin levels: a comprehensive review. CNS Drugs (2014) 1.18
Rat striatal methionine-enkephalin content after chronic treatment with cataleptogenic and noncataleptogenic antischizophrenic drugs. J Pharmacol Exp Ther (1978) 1.17
Determination of methionine enkephalin in discrete regions of rat brain. Brain Res (1977) 1.12
Localized epileptiform activity induced by murine CRF in rats. Epilepsia (1988) 1.10
Metformin-associated lactic acidosis requiring hospitalization. A national 10 year survey and a systematic literature review. Eur Rev Med Pharmacol Sci (2013) 1.08
Cannabinoid mechanism in reinstatement of heroin-seeking after a long period of abstinence in rats. Eur J Neurosci (2003) 1.08
CB1 cannabinoid receptor agonist WIN 55,212-2 decreases intravenous cocaine self-administration in rats. Behav Brain Res (1999) 1.06
Evidence for co-release of noradrenaline and dopamine from noradrenergic neurons in the cerebral cortex. Mol Psychiatry (2001) 1.05
1-(2',4'-dichlorophenyl)-6-methyl-N-cyclohexylamine-1,4-dihydroindeno[1,2-c]pyrazole-3-carboxamide, a novel CB2 agonist, alleviates neuropathic pain through functional microglial changes in mice. Neurobiol Dis (2009) 1.03
Drug- and cue-induced reinstatement of cannabinoid-seeking behaviour in male and female rats: influence of ovarian hormones. Br J Pharmacol (2010) 1.03
The human eye expresses high levels of CB1 cannabinoid receptor mRNA and protein. Eur J Neurosci (2000) 0.98
Detection of two endorphin-like peptides in nucleus caudatus. Neuropharmacology (1978) 0.98
Rat brain enkephalins: distribution and biosynthesis. Adv Biochem Psychopharmacol (1978) 0.97
Benzodiazepine-induced voraciousness in cats and inhibition of amphetamine-anorexia. Life Sci (1976) 0.97
Cannabinoid receptor CB1 mRNA is highly expressed in the rat ciliary body: implications for the antiglaucoma properties of marihuana. Brain Res Mol Brain Res (1998) 0.96
Chronic treatment with haloperidol accelerates the biosynthesis of enkephalins in rat striatum. Brain Res (1979) 0.94
Duration and stability of the rapid-cycling course: a long-term personal follow-up of 109 patients. J Affect Disord (2003) 0.93
Differences in the opioid system in selected brain regions of alcohol-preferring and alcohol-nonpreferring rats. Alcohol Clin Exp Res (1999) 0.92
Astroglial in vivo response to cocaine in mouse dentate gyrus: a quantitative and qualitative analysis by confocal microscopy. Neuroscience (2002) 0.91
Pharmacology of neurosteroid biosynthesis. Role of the mitochondrial DBI receptor (MDR) complex. Ann N Y Acad Sci (1994) 0.90
Fidia and neuroscience. Nature (1993) 0.90
The future is now: model-based clinical trial design for Alzheimer's disease. Clin Pharmacol Ther (2014) 0.89
Postsynaptic receptors are not essential for dopaminergic feedback regulation. Nature (1977) 0.89
Neurobiological mechanisms of cannabinoid addiction. Mol Cell Endocrinol (2008) 0.89
Characterization of enkephalin-like material extracted from sympathetic ganglia. Neuropharmacology (1978) 0.89
The synthetic cannabinoid WIN55212-2 decreases the intraocular pressure in human glaucoma resistant to conventional therapies. Eur J Neurosci (2001) 0.89
Lack of morphine-induced dopamine release in the nucleus accumbens of cannabinoid CB(1) receptor knockout mice. Eur J Pharmacol (1999) 0.88
Stress-induced sleep deprivation modifies corticotropin releasing factor (CRF) levels and CRF binding in rat brain and pituitary. Pharmacol Res (1997) 0.87
In vitro excitatory actions of corticotropin-releasing factor on rat colonic motility. J Auton Pharmacol (1998) 0.87
Isradipine inhibits nicotine intravenous self-administration in drug-naive mice. Pharmacol Biochem Behav (1995) 0.87
Calcium antagonists isradipine and nimodipine suppress cocaine and morphine intravenous self-administration in drug-naive mice. Pharmacol Biochem Behav (1992) 0.87
Chronic morphine and naltrexone fail to modify mu-opioid receptor mRNA levels in the rat brain. Brain Res Mol Brain Res (1997) 0.86
Homosexual mounting behavior induced in male rats and rabbits by a tryptophan-free diet. Life Sci (1977) 0.86
The R100Q mutation of the GABA(A) alpha(6) receptor subunit may contribute to voluntary aversion to ethanol in the sNP rat line. Brain Res Mol Brain Res (2001) 0.86
The non-competitive NMDA-receptor antagonist MK-801 prevents the massive release of glutamate and aspartate from rat striatum induced by 1-methyl-4-phenylpyridinium (MPP+). Neurosci Lett (1990) 0.86
Interactions between enkephalinergic and other neuronal systems. Adv Biochem Psychopharmacol (1978) 0.85
Lead intoxication during intrauterine life and lactation but not during adulthood reduces nucleus accumbens dopamine release as studied by brain microdialysis. Toxicol Lett (2001) 0.85
Delta9-tetrahydrocannabinol increases sequence-specific AP-1 DNA-binding activity and Fos-related antigens in the rat brain. Eur J Neurosci (1998) 0.85
Enkephalin in bovine adrenal gland: multiple molecular forms of [Met5]-enkephalin immunoreactive peptides. Neuropharmacology (1980) 0.85
Thyroid involvement in patients with overt HCV-related mixed cryoglobulinaemia. QJM (2004) 0.85
Intravenous self-administration of gamma-hydroxybutyric acid in drug-naive mice. Eur Neuropsychopharmacol (1998) 0.84
Cytokine regulation of the liver transcription factor hepatocyte nuclear factor-3 beta is mediated by the C/EBP family and interferon regulatory factor 1. Cell Growth Differ (1995) 0.84
Cannabinoid-opioid interactions in drug discrimination and self-administration: effect of maternal, postnatal, adolescent and adult exposure to the drugs. Curr Drug Targets (2010) 0.84
Antidepressant-like effect of selective dopamine D1 receptor agonists in the behavioural despair animal model of depression. Eur J Pharmacol (1994) 0.83
Sleep deprivation increases dopamine D1 receptor antagonist [3H]SCH 23390 binding and dopamine-stimulated adenylate cyclase in the rat limbic system. Neurosci Lett (1990) 0.83
Sleep deprivation decreases mu and delta opioid receptor binding in the rat limbic system. Neurosci Lett (1991) 0.83
Reciprocal antagonism between ACTH1-24 and beta-endorphin in rats. Neurosci Lett (1981) 0.82
Correlation between increased AP-1NGF binding activity and induction of nerve growth factor transcription by multiple signal transduction pathways in C6-2B glioma cells. Brain Res Mol Brain Res (1996) 0.82
Neonatal monosodium glutamate abolishes corticotropin-releasing factor-induced epileptogenic activity in rats. Epilepsia (1991) 0.82
Decreased content of immunoreactive enkephalin-like peptide in peripheral tissues of spontaneously hypertensive rats. Nature (1979) 0.82
Corticotropin-releasing factor (CRF) increases paradoxical sleep (PS) rebound in PS-deprived rats. Brain Res (1990) 0.81
Dopamine D1 and opioid receptor binding changes in the limbic system of sleep deprived rats. Neurochem Int (1992) 0.81
Rewarding properties of gamma-hydroxybutyric acid: an evaluation through place preference paradigm. Psychopharmacology (Berl) (1997) 0.81
The calcium antagonist PN 200-110 inhibits the reinforcing properties of cocaine. Brain Res Bull (1991) 0.81
Chronic imipramine, L-sulpiride and mianserin decrease corticotropin releasing factor levels in the rat brain. Neurosci Lett (1995) 0.81
Gamma-hydroxybutyric acid: an evaluation of its rewarding properties in rats and mice. Alcohol (2000) 0.80
Differential effect of opioid and cannabinoid receptor blockade on heroin-seeking reinstatement and cannabinoid substitution in heroin-abstinent rats. Br J Pharmacol (2011) 0.80
Different epileptogenic activities of murine and ovine corticotropin-releasing factor. Brain Res (1987) 0.80
Changes in dopamine metabolism associated with fasting and satiation. Adv Biochem Psychopharmacol (1977) 0.80
Animal models of mania. Adv Biochem Psychopharmacol (1995) 0.80
Stress increases noradrenaline release in the rat frontal cortex: prevention by diazepam. Eur J Pharmacol (1990) 0.79
Aphrodisiac effect of L-DOPA and apomorphine in male sexually sluggish rats. Experientia (1974) 0.79
Chronic blockade of CB(1) receptors reverses startle gating deficits and associated neurochemical alterations in rats reared in isolation. Br J Pharmacol (2012) 0.79
Kartagener's syndrome and rheumatoid arthritis: an unusual association. Clin Rheumatol (2001) 0.79
Baclofen antagonises intravenous self-administration of gamma-hydroxybutyric acid in mice. Neuroreport (2001) 0.79
Effects of the calcium antagonist isradipine on cocaine intravenous self-administration in rats. Psychopharmacology (Berl) (1994) 0.78
The cyclo-oxygenase inhibitor nimesulide induces conditioned place preference in rats. Eur J Pharmacol (2000) 0.78
Gamma-hydroxybutyric acid decreases intravenous cocaine self-administration in rats. Pharmacol Biochem Behav (1998) 0.78
A comparison of continuous subcutaneous paliperidone infusion and repeated subcutaneous injection of risperidone free-base in rats. Eur Psychiatry (2009) 0.78
Stimulation of dopamine autoreceptors elicits "premature ejaculation" in rats. Pharmacol Biochem Behav (1984) 0.78
Cloning and tissue-specific functional characterization of the promoter of the rat diazepam binding inhibitor, a peptide with multiple biological actions. Proc Natl Acad Sci U S A (1993) 0.78
Distribution of beta-endorphin and related peptides in the hypothalamus and pituitary. Neuroscience (1979) 0.77
C-Fos expression as a molecular marker in corticotropin-releasing factor-induced seizures. Synapse (1996) 0.77
Oxytocin concentration changes in different rat brain areas but not in plasma during aging. Neurobiol Aging (1993) 0.77
The long term prophylaxis of affective disorders. Adv Biochem Psychopharmacol (1995) 0.77
Hypophysectomy prevents ACTH-induced yawning and penile erection in rats. Pharmacol Biochem Behav (1987) 0.77